What clinical trials are currently recruiting in Nevada?

TrialFinder lists 564 recruiting clinical trials with sites in or near Nevada. Results cover a wide range of conditions and are updated regularly from ClinicalTrials.gov.

Do I need insurance to join a clinical trial in Nevada?

No. Study-related care is covered by the trial sponsor at no cost to participants. This includes the experimental treatment, required lab tests, and study visits. Many trials also provide compensation for time and travel. Health insurance is not required to search or enroll.

What conditions have clinical trials recruiting in Nevada?

Trials in Nevada cover a broad range of conditions including cancer, diabetes, heart disease, neurological disorders, autoimmune diseases, mental health conditions, and more. Use TrialFinder to search by specific condition and location.

How do I sign up for a clinical trial in Nevada?

Find a trial that matches your condition on TrialFinder, review the eligibility criteria, and contact the research site listed on the trial detail page. Most research teams will conduct a brief phone pre-screening before any in-person visit. You can also create a free TrialFinder profile to get matched to recruiting trials near you.

564 Recruiting Trials

Clinical Trials in Nevada

Browse 564 recruiting clinical trials currently enrolling participants in Nevada. Search by condition to find trials you may qualify for — at no cost.

Showing 15 of 564 recruiting trials in Nevada

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

PHASE3 Anchorage, Alaska +4 sites · Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8

Recruiting

A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

PHASE3 Phoenix, Arizona +4 sites · Stereotypical Prolonged Seizures

Recruiting

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

PHASE2 Birmingham, Alabama +4 sites · Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma

Recruiting

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

PHASE2 Glendale, Arizona +4 sites · Diffuse Large B-Cell Lymphoma, DLBCL

Recruiting

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

PHASE3 Birmingham, Alabama +4 sites · Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma

Recruiting

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

PHASE2 Birmingham, Alabama +4 sites · Acute Myeloid Leukemia, Myelodysplastic Syndrome

Recruiting

A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251

PHASE2 Beverly Hills, California +4 sites · Geographic Atrophy

Recruiting

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

PHASE3 Birmingham, Alabama +4 sites · Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

Recruiting

Alleviant ALLAY-HF Study

NA Phoenix, Arizona +4 sites · Heart Failure

Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

PHASE2 Birmingham, Alabama +4 sites · Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis

Recruiting

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

PHASE4 Anchorage, Alaska +4 sites · Antineutrophil Cytoplasmic Antibody-associated Vasculitis

Recruiting

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

PHASE3 Little Rock, Arkansas +4 sites · Non Small Cell Lung Cancer

Recruiting

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

PHASE2 Chandler, Arizona +4 sites · Non-Small Cell Lung Cancer

Recruiting

A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting

PHASE4 Birmingham, Alabama +4 sites · Crohn's Disease, Ulcerative Colitis

Recruiting

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

PHASE3 Cullman, Alabama +4 sites · Coronavirus Disease (COVID-19)

Recruiting

See all 564 results in Nevada

Check Your Eligibility

Create a free profile and our AI will match you to trials in Nevada you may qualify for.

Get Matched — Free

No insurance required

Search by Condition in Nevada

Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19

Browse Other States

California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon